HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic Target
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic Target
Authors
Keywords
HDL, Cholesterol efflux, Reverse cholesterol transport, Atherosclerosis, Cardiovascular
Journal
Current Atherosclerosis Reports
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-12-29
DOI
10.1007/s11883-015-0554-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease
- (2015) Tetsuya Ishikawa et al. ATHEROSCLEROSIS
- Niacin Therapy, HDL Cholesterol, and Cardiovascular Disease: Is the HDL Hypothesis Defunct?
- (2015) Preethi Mani et al. Current Atherosclerosis Reports
- Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis
- (2015) Taufiq Salahuddin et al. EUROPEAN HEART JOURNAL
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
- (2015) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity
- (2015) Anand Rohatgi PROGRESS IN CARDIOVASCULAR DISEASES
- Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study
- (2015) Danish Saleheen et al. Lancet Diabetes & Endocrinology
- CSL112 Enhances Biomarkers of Reverse Cholesterol Transport After Single and Multiple Infusions in Healthy Subjects
- (2014) Andreas Gille et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial
- (2014) Kausik K. Ray et al. EUROPEAN HEART JOURNAL
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
- (2014) Anand Rohatgi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients
- (2014) D. Keene et al. BMJ-British Medical Journal
- Novel Formulation of a Reconstituted High-Density Lipoprotein (CSL112) Dramatically Enhances ABCA1-Dependent Cholesterol Efflux
- (2013) Svetlana Diditchenko et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Paradoxical Association of Enhanced Cholesterol Efflux With Increased Incident Cardiovascular Risks
- (2013) Xin-Min Li et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality
- (2013) Marcin Barylski et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. CIRCULATION
- Reconstituted HDL for the acute treatment of acute coronary syndrome
- (2013) Brian R. Krause et al. CURRENT OPINION IN LIPIDOLOGY
- The Addition of Niacin to Statin Therapy Improves High-Density Lipoprotein Cholesterol Levels But Not Metrics of Functionality
- (2013) Amit V. Khera et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- FAMP, a Novel ApoA‐I Mimetic Peptide, Suppresses Aortic Plaque Formation Through Promotion of Biological HDL Function in ApoE‐Deficient Mice
- (2013) Yoshinari Uehara et al. Journal of the American Heart Association
- ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies
- (2012) Stephen J. Nicholls et al. CARDIOVASCULAR DRUGS AND THERAPY
- Cholesterol Efflux and Atheroprotection
- (2012) Robert S. Rosenson et al. CIRCULATION
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lecithin Cholesterol Acyltransferase: An Anti- or Pro-atherogenic Factor?
- (2011) Xavier Rousset et al. Current Atherosclerosis Reports
- Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol
- (2011) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease
- (2011) Stephen J. Nicholls et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
- (2011) Amit V. Khera et al. NEW ENGLAND JOURNAL OF MEDICINE
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib
- (2010) Laurent Yvan-Charvet et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- 5A Apolipoprotein Mimetic Peptide Promotes Cholesterol Efflux and Reduces Atherosclerosis in Mice
- (2010) M. J. A. Amar et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- RVX-208
- (2010) Dana Bailey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lecithin:Cholesterol Acyltransferase, High-Density Lipoproteins, and Atheroprotection in Humans
- (2010) Laura Calabresi et al. TRENDS IN CARDIOVASCULAR MEDICINE
- High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: Possible attenuation of cardioprotection associated with high HDL cholesterol
- (2009) Robin P.F. Dullaart et al. ATHEROSCLEROSIS
- Lecithin: Cholesterol Acyltransferase Expression Has Minimal Effects on Macrophage Reverse Cholesterol Transport In Vivo
- (2009) Hiroyuki Tanigawa et al. CIRCULATION
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population study
- (2009) A. G. Holleboom et al. JOURNAL OF LIPID RESEARCH
- HDL, ABC Transporters, and Cholesterol Efflux: Implications for the Treatment of Atherosclerosis
- (2008) Alan R. Tall et al. Cell Metabolism
- High-Density Lipoprotein Cholesterol, High-Density Lipoprotein Particle Size, and Apolipoprotein A-I: Significance for Cardiovascular Risk
- (2008) Wim A. van der Steeg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Combined Deletion of Macrophage ABCA1 and ABCG1 Leads to Massive Lipid Accumulation in Tissue Macrophages and Distinct Atherosclerosis at Relatively Low Plasma Cholesterol Levels
- (2007) Ruud Out et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Progression of calcified coronary atherosclerosis: Relationship to coronary risk factors and carotid intima-media thickness
- (2007) Allen J. Taylor et al. ATHEROSCLEROSIS
- Normal Value of Carotid Intima-Media Thickness–A Surrogate Marker of Atherosclersosis: Quantitative Assessment by B-Mode Carotid Ultrasound
- (2007) Tiong K. Lim et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started